Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1988 Aug;26(8):1519–1523. doi: 10.1128/jcm.26.8.1519-1523.1988

Detection of nephropathia epidemica (Puumala virus)-specific immunoglobulin M by enzyme-linked immunosorbent assay.

B Niklasson 1, T Kjelsson 1
PMCID: PMC266653  PMID: 2902106

Abstract

Nephropathia epidemica (NE), a less severe form of hemorrhagic fever with renal syndrome, is caused by Puumala virus (PUU). This communication reports the development of a mu-capture enzyme-linked immunosorbent assay (ELISA) for detection of specific immunoglobulin M (IgM) antibodies to PUU virus in human sera. Acute- and early-convalescent-phase sera (collected 1 to 41 days after disease onset) from 29 Swedish patients with clinical NE were tested for PUU virus-specific IgG and IgM antibodies by the indirect immunofluorescence test and ELISA, respectively. Late-convalescent-phase serum was also collected from 18 of these patients 3 to 24 months postinfection and assayed. The IgM ELISA values were strongly positive in sera collected during the first 2 months; at 3 to 9 months, they were negative or in the lower range of significance, and at 24 months all sera were negative. Paired sera from NE patients often fail to show seroconversion or a significant titer rise when tested by indirect immunofluorescence. Since all acute- and early-convalescent-phase sera were positive by IgM ELISA, this test could become an important tool for early diagnosis of acute human NE infections.

Full text

PDF
1519

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benito R. J., Larrad L., Lasierra M. P., Benito J. F., Erdociaín F. Persistence of specific IgM antibodies after natural mumps infection. J Infect Dis. 1987 Jan;155(1):156–157. doi: 10.1093/infdis/155.1.156. [DOI] [PubMed] [Google Scholar]
  2. Buchner Y. I., Heath R. B., Collins J. V., Pattison J. R. Serum IgM antibody and influenza A infection. J Clin Pathol. 1977 Aug;30(8):723–727. doi: 10.1136/jcp.30.8.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Johansson M. E., Espmark J. A. Elimination of inter-species reactive anti-IgG antibodies by affinity chromatography. J Immunol Methods. 1978;21(3-4):285–293. doi: 10.1016/0022-1759(78)90155-2. [DOI] [PubMed] [Google Scholar]
  4. Johansson M. E., Wadell G., Jacobsson P. A., Svensson L. Preparation of specific antisera against adenoviruses by affinity bead immunization (ABI). J Immunol Methods. 1979;26(2):141–149. doi: 10.1016/0022-1759(79)90077-2. [DOI] [PubMed] [Google Scholar]
  5. Lemon S. M., Brown C. D., Brooks D. S., Simms T. E., Bancroft W. H. Specific immunoglobulin M response to hepatitis A virus determined by solid-phase radioimmunoassay. Infect Immun. 1980 Jun;28(3):927–936. doi: 10.1128/iai.28.3.927-936.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Myasnikov YuA, Rezapkin G. V., Shuikova Z. V., Tkachenko E. A., Ivanova A. A., Nurgaleeva R. G., Stepanenko A. G., Vereshchagin N. N., Loginov A. I., Bagan R. N. Antibodies to the HFRS virus in the human population of European RSFSR as detected by radioimmunoassay. Arch Virol. 1984;79(1-2):109–115. doi: 10.1007/BF01314308. [DOI] [PubMed] [Google Scholar]
  7. Niklasson B., Le Duc J. Isolation of the nephropathia epidemica agent in Sweden. Lancet. 1984 May 5;1(8384):1012–1013. doi: 10.1016/s0140-6736(84)92344-4. [DOI] [PubMed] [Google Scholar]
  8. Niklasson B., LeDuc J. W. Epidemiology of nephropathia epidemica in Sweden. J Infect Dis. 1987 Feb;155(2):269–276. doi: 10.1093/infdis/155.2.269. [DOI] [PubMed] [Google Scholar]
  9. Niklasson B., Leduc J., Nyström K., Nyman L. Nephropathia epidemica: incidence of clinical cases and antibody prevalence in an endemic area of Sweden. Epidemiol Infect. 1987 Oct;99(2):559–562. doi: 10.1017/s0950268800068060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Niklasson B., Nyman L., Linde A., Grandien M., Dalrymple J. An epidemiological survey of nephropathia epidemica in Sweden. Scand J Infect Dis. 1983;15(3):239–245. doi: 10.3109/inf.1983.15.issue-3.03. [DOI] [PubMed] [Google Scholar]
  11. Pattison J. R. Persistence of specific IgM after natural infection with rubella virus. Lancet. 1975 Jan 25;1(7900):185–187. doi: 10.1016/s0140-6736(75)91357-4. [DOI] [PubMed] [Google Scholar]
  12. Penttinen K., Lähdevirta J., Kekomäki R., Ziola B., Salmi A., Hautanen A., Lindström P., Vaheri A., Brummer-Korvenkontio M., Wager O. Circulating immune complexes, immunoconglutinins, and rheumatoid factors in nephropathia epidemica. J Infect Dis. 1981 Jan;143(1):15–21. doi: 10.1093/infdis/143.1.15. [DOI] [PubMed] [Google Scholar]
  13. Salonen E. M., Vaheri A., Suni J., Wager O. Rheumatoid factor in acute viral infections: interference with determination of IgM, IgG, and IgA antibodies in an enzyme immunoassay. J Infect Dis. 1980 Aug;142(2):250–255. doi: 10.1093/infdis/142.2.250. [DOI] [PubMed] [Google Scholar]
  14. Schmaljohn C. S., Hasty S. E., Dalrymple J. M., LeDuc J. W., Lee H. W., von Bonsdorff C. H., Brummer-Korvenkontio M., Vaheri A., Tsai T. F., Regnery H. L. Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science. 1985 Mar 1;227(4690):1041–1044. doi: 10.1126/science.2858126. [DOI] [PubMed] [Google Scholar]
  15. Settergren B., Juto P., Wadell G. Detection of specific serum immunoglobulin M in nephropathia epidemica (Scandinavian epidemic nephropathy) by a biotin-avidin-amplified immunofluorescence method. J Clin Microbiol. 1987 Jun;25(6):1134–1136. doi: 10.1128/jcm.25.6.1134-1136.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. van der Groen G. Haemorrhagic fever with renal syndrome: recent developments. Ann Soc Belg Med Trop. 1985 Jun;65(2):121–135. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES